img

Global Celiac Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Celiac Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Celiac Disease Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Celiac Disease Drug market is projected to reach US$ 1603.3 million in 2034, increasing from US$ 597.3 million in 2022, with the CAGR of 14.9% during the period of 2024 to 2034. Demand from First Line of Treatment and Second Line of Treatment are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Celiac Disease Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Celiac Disease Drug key manufacturers include F. Hoffmann-La Roche, Johnson & Johnson, Merck, Pfizer, ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer and Biogen, etc. F. Hoffmann-La Roche, Johnson & Johnson, Merck are top 3 players and held % sales share in total in 2022.
Celiac Disease Drug can be divided into Distension, Diarrhea, Anorexia and Others, etc. Distension is the mainstream product in the market, accounting for % sales share globally in 2022.
Celiac Disease Drug is widely used in various fields, such as First Line of Treatment and Second Line of Treatment, etc. First Line of Treatment provides greatest supports to the Celiac Disease Drug industry development. In 2022, global % sales of Celiac Disease Drug went into First Line of Treatment filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Celiac Disease Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


F. Hoffmann-La Roche
Johnson & Johnson
Merck
Pfizer
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Takeda Pharmaceutical
Novartis
LFB Group
Kedrion Biopharma
Segment by Type
Distension
Diarrhea
Anorexia
Others

Segment by Application


First Line of Treatment
Second Line of Treatment

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Celiac Disease Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Celiac Disease Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Celiac Disease Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Celiac Disease Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Celiac Disease Drug introduction, etc. Celiac Disease Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Celiac Disease Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Celiac Disease Drug Market Overview
1.1 Celiac Disease Drug Product Overview
1.2 Celiac Disease Drug Market Segment by Type
1.2.1 Distension
1.2.2 Diarrhea
1.2.3 Anorexia
1.2.4 Others
1.3 Global Celiac Disease Drug Market Size by Type
1.3.1 Global Celiac Disease Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Celiac Disease Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Celiac Disease Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Celiac Disease Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Celiac Disease Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Celiac Disease Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Celiac Disease Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Celiac Disease Drug Sales Breakdown by Type (2018-2024)
2 Global Celiac Disease Drug Market Competition by Company
2.1 Global Top Players by Celiac Disease Drug Sales (2018-2024)
2.2 Global Top Players by Celiac Disease Drug Revenue (2018-2024)
2.3 Global Top Players by Celiac Disease Drug Price (2018-2024)
2.4 Global Top Manufacturers Celiac Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Celiac Disease Drug Market Competitive Situation and Trends
2.5.1 Celiac Disease Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Celiac Disease Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Celiac Disease Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Celiac Disease Drug Market
2.8 Key Manufacturers Celiac Disease Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Celiac Disease Drug Status and Outlook by Region
3.1 Global Celiac Disease Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Celiac Disease Drug Historic Market Size by Region
3.2.1 Global Celiac Disease Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Celiac Disease Drug Sales in Value by Region (2018-2024)
3.2.3 Global Celiac Disease Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Celiac Disease Drug Forecasted Market Size by Region
3.3.1 Global Celiac Disease Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Celiac Disease Drug Sales in Value by Region (2024-2034)
3.3.3 Global Celiac Disease Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Celiac Disease Drug by Application
4.1 Celiac Disease Drug Market Segment by Application
4.1.1 First Line of Treatment
4.1.2 Second Line of Treatment
4.2 Global Celiac Disease Drug Market Size by Application
4.2.1 Global Celiac Disease Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Celiac Disease Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Celiac Disease Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Celiac Disease Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Celiac Disease Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Celiac Disease Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Celiac Disease Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Celiac Disease Drug Sales Breakdown by Application (2018-2024)
5 North America Celiac Disease Drug by Country
5.1 North America Celiac Disease Drug Historic Market Size by Country
5.1.1 North America Celiac Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Celiac Disease Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Celiac Disease Drug Sales in Value by Country (2018-2024)
5.2 North America Celiac Disease Drug Forecasted Market Size by Country
5.2.1 North America Celiac Disease Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Celiac Disease Drug Sales in Value by Country (2024-2034)
6 Europe Celiac Disease Drug by Country
6.1 Europe Celiac Disease Drug Historic Market Size by Country
6.1.1 Europe Celiac Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Celiac Disease Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Celiac Disease Drug Sales in Value by Country (2018-2024)
6.2 Europe Celiac Disease Drug Forecasted Market Size by Country
6.2.1 Europe Celiac Disease Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Celiac Disease Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Celiac Disease Drug by Region
7.1 Asia-Pacific Celiac Disease Drug Historic Market Size by Region
7.1.1 Asia-Pacific Celiac Disease Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Celiac Disease Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Celiac Disease Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Celiac Disease Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Celiac Disease Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Celiac Disease Drug Sales in Value by Region (2024-2034)
8 Latin America Celiac Disease Drug by Country
8.1 Latin America Celiac Disease Drug Historic Market Size by Country
8.1.1 Latin America Celiac Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Celiac Disease Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Celiac Disease Drug Sales in Value by Country (2018-2024)
8.2 Latin America Celiac Disease Drug Forecasted Market Size by Country
8.2.1 Latin America Celiac Disease Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Celiac Disease Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Celiac Disease Drug by Country
9.1 Middle East and Africa Celiac Disease Drug Historic Market Size by Country
9.1.1 Middle East and Africa Celiac Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Celiac Disease Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Celiac Disease Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Celiac Disease Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Celiac Disease Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Celiac Disease Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 F. Hoffmann-La Roche
10.1.1 F. Hoffmann-La Roche Company Information
10.1.2 F. Hoffmann-La Roche Introduction and Business Overview
10.1.3 F. Hoffmann-La Roche Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 F. Hoffmann-La Roche Celiac Disease Drug Products Offered
10.1.5 F. Hoffmann-La Roche Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Johnson & Johnson Celiac Disease Drug Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck Celiac Disease Drug Products Offered
10.3.5 Merck Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer Celiac Disease Drug Products Offered
10.4.5 Pfizer Recent Development
10.5 ADMA Biologics
10.5.1 ADMA Biologics Company Information
10.5.2 ADMA Biologics Introduction and Business Overview
10.5.3 ADMA Biologics Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 ADMA Biologics Celiac Disease Drug Products Offered
10.5.5 ADMA Biologics Recent Development
10.6 Amgen
10.6.1 Amgen Company Information
10.6.2 Amgen Introduction and Business Overview
10.6.3 Amgen Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Amgen Celiac Disease Drug Products Offered
10.6.5 Amgen Recent Development
10.7 Anthera Pharmaceuticals
10.7.1 Anthera Pharmaceuticals Company Information
10.7.2 Anthera Pharmaceuticals Introduction and Business Overview
10.7.3 Anthera Pharmaceuticals Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Anthera Pharmaceuticals Celiac Disease Drug Products Offered
10.7.5 Anthera Pharmaceuticals Recent Development
10.8 Bayer
10.8.1 Bayer Company Information
10.8.2 Bayer Introduction and Business Overview
10.8.3 Bayer Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bayer Celiac Disease Drug Products Offered
10.8.5 Bayer Recent Development
10.9 Biogen
10.9.1 Biogen Company Information
10.9.2 Biogen Introduction and Business Overview
10.9.3 Biogen Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Biogen Celiac Disease Drug Products Offered
10.9.5 Biogen Recent Development
10.10 BioLineRx
10.10.1 BioLineRx Company Information
10.10.2 BioLineRx Introduction and Business Overview
10.10.3 BioLineRx Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 BioLineRx Celiac Disease Drug Products Offered
10.10.5 BioLineRx Recent Development
10.11 Biotest
10.11.1 Biotest Company Information
10.11.2 Biotest Introduction and Business Overview
10.11.3 Biotest Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Biotest Celiac Disease Drug Products Offered
10.11.5 Biotest Recent Development
10.12 Bristol-Myers Squibb
10.12.1 Bristol-Myers Squibb Company Information
10.12.2 Bristol-Myers Squibb Introduction and Business Overview
10.12.3 Bristol-Myers Squibb Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Bristol-Myers Squibb Celiac Disease Drug Products Offered
10.12.5 Bristol-Myers Squibb Recent Development
10.13 Celgene
10.13.1 Celgene Company Information
10.13.2 Celgene Introduction and Business Overview
10.13.3 Celgene Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Celgene Celiac Disease Drug Products Offered
10.13.5 Celgene Recent Development
10.14 Takeda Pharmaceutical
10.14.1 Takeda Pharmaceutical Company Information
10.14.2 Takeda Pharmaceutical Introduction and Business Overview
10.14.3 Takeda Pharmaceutical Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Takeda Pharmaceutical Celiac Disease Drug Products Offered
10.14.5 Takeda Pharmaceutical Recent Development
10.15 Novartis
10.15.1 Novartis Company Information
10.15.2 Novartis Introduction and Business Overview
10.15.3 Novartis Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Novartis Celiac Disease Drug Products Offered
10.15.5 Novartis Recent Development
10.16 LFB Group
10.16.1 LFB Group Company Information
10.16.2 LFB Group Introduction and Business Overview
10.16.3 LFB Group Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 LFB Group Celiac Disease Drug Products Offered
10.16.5 LFB Group Recent Development
10.17 Kedrion Biopharma
10.17.1 Kedrion Biopharma Company Information
10.17.2 Kedrion Biopharma Introduction and Business Overview
10.17.3 Kedrion Biopharma Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Kedrion Biopharma Celiac Disease Drug Products Offered
10.17.5 Kedrion Biopharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Celiac Disease Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Celiac Disease Drug Industrial Chain Analysis
11.4 Celiac Disease Drug Market Dynamics
11.4.1 Celiac Disease Drug Industry Trends
11.4.2 Celiac Disease Drug Market Drivers
11.4.3 Celiac Disease Drug Market Challenges
11.4.4 Celiac Disease Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Celiac Disease Drug Distributors
12.3 Celiac Disease Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Distension
Table 2. Major Company of Diarrhea
Table 3. Major Company of Anorexia
Table 4. Major Company of Others
Table 5. Global Celiac Disease Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Celiac Disease Drug Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Celiac Disease Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Celiac Disease Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Celiac Disease Drug Market Share in Value by Type (2018-2024)
Table 10. Global Celiac Disease Drug Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Celiac Disease Drug Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Celiac Disease Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Celiac Disease Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Celiac Disease Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Celiac Disease Drug Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Celiac Disease Drug Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Celiac Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Celiac Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Celiac Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Celiac Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Celiac Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Celiac Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Celiac Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Celiac Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Celiac Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Celiac Disease Drug Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Celiac Disease Drug Sales Share by Company (2018-2024)
Table 28. Global Celiac Disease Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Celiac Disease Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Celiac Disease Drug Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Celiac Disease Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Celiac Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Celiac Disease Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Celiac Disease Drug Market
Table 35. Key Manufacturers Celiac Disease Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Celiac Disease Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Celiac Disease Drug Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Celiac Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Celiac Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Celiac Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Celiac Disease Drug Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Celiac Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Celiac Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Celiac Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Celiac Disease Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Celiac Disease Drug Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Celiac Disease Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Celiac Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Celiac Disease Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Celiac Disease Drug Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Celiac Disease Drug Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Celiac Disease Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Celiac Disease Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Celiac Disease Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Celiac Disease Drug Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Celiac Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 60. North America Celiac Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Celiac Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Celiac Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Celiac Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Celiac Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Celiac Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Celiac Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Celiac Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Celiac Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Celiac Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Celiac Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Celiac Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Celiac Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Celiac Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Celiac Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Celiac Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Celiac Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Celiac Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Celiac Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Celiac Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Celiac Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Celiac Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Celiac Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Celiac Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Celiac Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Celiac Disease Drug Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Celiac Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Celiac Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Celiac Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Celiac Disease Drug Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Celiac Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Celiac Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Celiac Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Celiac Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Celiac Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Celiac Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Celiac Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Celiac Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Celiac Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Celiac Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Celiac Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Celiac Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Celiac Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Celiac Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Celiac Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Celiac Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Celiac Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Celiac Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Celiac Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 109. F. Hoffmann-La Roche Company Information
Table 110. F. Hoffmann-La Roche Introduction and Business Overview
Table 111. F. Hoffmann-La Roche Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. F. Hoffmann-La Roche Celiac Disease Drug Product
Table 113. F. Hoffmann-La Roche Recent Development
Table 114. Johnson & Johnson Company Information
Table 115. Johnson & Johnson Introduction and Business Overview
Table 116. Johnson & Johnson Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Johnson & Johnson Celiac Disease Drug Product
Table 118. Johnson & Johnson Recent Development
Table 119. Merck Company Information
Table 120. Merck Introduction and Business Overview
Table 121. Merck Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Merck Celiac Disease Drug Product
Table 123. Merck Recent Development
Table 124. Pfizer Company Information
Table 125. Pfizer Introduction and Business Overview
Table 126. Pfizer Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Pfizer Celiac Disease Drug Product
Table 128. Pfizer Recent Development
Table 129. ADMA Biologics Company Information
Table 130. ADMA Biologics Introduction and Business Overview
Table 131. ADMA Biologics Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. ADMA Biologics Celiac Disease Drug Product
Table 133. ADMA Biologics Recent Development
Table 134. Amgen Company Information
Table 135. Amgen Introduction and Business Overview
Table 136. Amgen Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. Amgen Celiac Disease Drug Product
Table 138. Amgen Recent Development
Table 139. Anthera Pharmaceuticals Company Information
Table 140. Anthera Pharmaceuticals Introduction and Business Overview
Table 141. Anthera Pharmaceuticals Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. Anthera Pharmaceuticals Celiac Disease Drug Product
Table 143. Anthera Pharmaceuticals Recent Development
Table 144. Bayer Company Information
Table 145. Bayer Introduction and Business Overview
Table 146. Bayer Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. Bayer Celiac Disease Drug Product
Table 148. Bayer Recent Development
Table 149. Biogen Company Information
Table 150. Biogen Introduction and Business Overview
Table 151. Biogen Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. Biogen Celiac Disease Drug Product
Table 153. Biogen Recent Development
Table 154. BioLineRx Company Information
Table 155. BioLineRx Introduction and Business Overview
Table 156. BioLineRx Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 157. BioLineRx Celiac Disease Drug Product
Table 158. BioLineRx Recent Development
Table 159. Biotest Company Information
Table 160. Biotest Introduction and Business Overview
Table 161. Biotest Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 162. Biotest Celiac Disease Drug Product
Table 163. Biotest Recent Development
Table 164. Bristol-Myers Squibb Company Information
Table 165. Bristol-Myers Squibb Introduction and Business Overview
Table 166. Bristol-Myers Squibb Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 167. Bristol-Myers Squibb Celiac Disease Drug Product
Table 168. Bristol-Myers Squibb Recent Development
Table 169. Celgene Company Information
Table 170. Celgene Introduction and Business Overview
Table 171. Celgene Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 172. Celgene Celiac Disease Drug Product
Table 173. Celgene Recent Development
Table 174. Takeda Pharmaceutical Company Information
Table 175. Takeda Pharmaceutical Introduction and Business Overview
Table 176. Takeda Pharmaceutical Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 177. Takeda Pharmaceutical Celiac Disease Drug Product
Table 178. Takeda Pharmaceutical Recent Development
Table 179. Novartis Company Information
Table 180. Novartis Introduction and Business Overview
Table 181. Novartis Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 182. Novartis Celiac Disease Drug Product
Table 183. Novartis Recent Development
Table 184. LFB Group Company Information
Table 185. LFB Group Introduction and Business Overview
Table 186. LFB Group Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 187. LFB Group Celiac Disease Drug Product
Table 188. LFB Group Recent Development
Table 189. Kedrion Biopharma Company Information
Table 190. Kedrion Biopharma Introduction and Business Overview
Table 191. Kedrion Biopharma Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 192. Kedrion Biopharma Celiac Disease Drug Product
Table 193. Kedrion Biopharma Recent Development
Table 194. Key Raw Materials Lists
Table 195. Raw Materials Key Suppliers Lists
Table 196. Celiac Disease Drug Market Trends
Table 197. Celiac Disease Drug Market Drivers
Table 198. Celiac Disease Drug Market Challenges
Table 199. Celiac Disease Drug Market Restraints
Table 200. Celiac Disease Drug Distributors List
Table 201. Celiac Disease Drug Downstream Customers
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Celiac Disease Drug Product Picture
Figure 2. Global Celiac Disease Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Celiac Disease Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Celiac Disease Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Distension
Figure 6. Global Distension Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Diarrhea
Figure 8. Global Diarrhea Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Anorexia
Figure 10. Global Anorexia Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Celiac Disease Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Celiac Disease Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Celiac Disease Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Celiac Disease Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Celiac Disease Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Celiac Disease Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Celiac Disease Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Celiac Disease Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Celiac Disease Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Celiac Disease Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Celiac Disease Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Celiac Disease Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Celiac Disease Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Celiac Disease Drug Revenue in 2022
Figure 27. Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of First Line of Treatment
Figure 29. Global First Line of Treatment Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Second Line of Treatment
Figure 31. Global Second Line of Treatment Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Global Celiac Disease Drug Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Celiac Disease Drug Sales Market Share by Application in 2022 & 2034
Figure 34. North America Celiac Disease Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Celiac Disease Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Celiac Disease Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Celiac Disease Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Celiac Disease Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Celiac Disease Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Celiac Disease Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Celiac Disease Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Celiac Disease Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Celiac Disease Drug Manufacturing Cost Structure
Figure 45. Celiac Disease Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries